Clinical Trial Update: Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity [NA]

View source ↗

Summary

Completed trial evaluating the EndoBarrier device for safety and efficacy in adults with type 2 diabetes and obesity; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• EndoBarrier (duodenal-jejunal bypass liner)

Snippet

Sponsor: Morphic Medical Inc. | Conditions: Type II Diabetes | NA | Status: COMPLETED | Results posted: 2016-10-03